ad

6523 達爾膚生醫科技

本益成長比: N/A  總報酬本益比: N/A  合理價格(本益比法): 469.35  合理價格(ROE法): 139.28
達爾膚生醫科技
  • EPS 年複合成長率: 15.72% (109-105)
  • 營業利益年複合成長率: N/A% (109-105)
  • 本益比: 5.46
  • 近四季EPS總合: 16.45 (2.31,0.54,1.88,11.72)
  • 融資餘額佔股本比例:2.78%
  • 融資使用率: 11.14%
  • 近期收盤價: 89.8 (2022-01-25)

股價漲跌幅

202220212020
達爾膚生醫科技-1.0%47.0%1.0%
0050-3.24%50.48%14.17%


營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近5年

20202019201820172016
營業毛利率67.3669.4060.8462.9669.14
營業利益率31.0423.217.3515.2733.26
折舊負擔比率1.572.071.870.850.43
稅前淨利率103.7222.506.5715.8232.58
股東權益報酬率34.0610.671.396.4920.77
資產報酬率30.669.721.265.9418.84
本業收入比29.89103.07112.7096.62102.13
業外獲益比70.11-3.07-12.703.38-2.13
無形資產佔淨值比0.130.240.370.000.00




營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營業毛利率61.0558.1769.0167.7068.6761.2869.9680.06
營業利益率36.9430.6438.4028.7439.1316.6934.4836.04
折舊負擔比率0.601.281.261.431.302.131.641.27
稅前淨利率36.0224.8444.28298.2437.5512.8734.5433.04
股東權益報酬率6.061.344.3431.145.061.043.184.41
資產報酬率4.831.073.6327.574.280.832.743.88
本業收入比102.52124.1486.679.60103.45127.78100.00108.97
業外獲益比-2.52-24.1413.3390.40-4.60-27.780.00-8.97
無形資產佔淨值比0.090.090.120.130.190.240.240.24




現金流量-近5年 (1.避開近3年累計小於0的公司 2.營運現金流量要大於稅後淨利,除非受到應收帳款和存貨影響 3.營運現金流量不應該都是流出)

20202019201820172016
營運現金流量(百萬)30122412194281
自由現金流量(百萬)7198311014-203
稅後淨利(百萬)66119225127312




現金流量-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營運現金流量(百萬)55-1113151258343101
自由現金流量(百萬)39053484616512173-67
稅後淨利(百萬)104258552869145181




成長能力-近5年 (營業利益和稅後淨利成長率要大於營業收入成長率)

20202019201820172016
營業收入(百萬)76510149639371151
營業利益(百萬)23723571143383
稅後淨利(百萬)66119225127312
EPS(完全稀釋)14.634.260.552.787.05
營業收入成長率(%)-24.565.302.77-18.5933.06
營業利益成長率(%)0.85230.99-50.35-62.6644.53
稅後淨利成長率(%)244.27668.00-80.31-59.2936.84
EPS成長率(%)243.43674.55-80.22-60.57-12.96




成長能力-近4季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營業收入(百萬)331235238210231141183236
營業利益(百萬)12272916090236385
稅後淨利(百萬)104258552869145181
EPS(完全稀釋)2.310.541.8811.721.530.301.131.80
去年同期營業收入成長率(%)43.2966.6730.05-11.02----
去年同期營業利益成長率(%)35.56213.0444.44-29.41----
去年同期稅後淨利成長率(%)50.7278.5766.67551.85----
去年同期EPS成長率(%)50.9880.0066.37551.11----
較上季營業收入成長率(%)40.85-1.2613.33-9.0963.83-22.95-22.46-
較上季營業利益成長率(%)69.44-20.8851.67-33.33291.30-63.49-25.88-
較上季稅後淨利成長率(%)316.00-70.59-83.90665.22392.86-72.55-37.04-
較上季EPS成長率(%)327.78-71.28-83.96666.01410.00-73.45-37.22-




每月營收變化

年/月月增率(%)去年同期年增率(%)累計營收年增率(%)
2021/12-35.915.9344.64
2021/11-4.1336.4347.18
2021/10-0.0680.4748.61
2021/9-3.3554.6644.88
2021/830.9862.143.33
2021/725.415.4639.86

稅前淨利較去年同期

2021Q3(百萬)2020Q3(百萬)YoY(%)
119.087.036.781
2021Q2(百萬)2020Q2(百萬)YoY(%)
58.018.0222.22
2021Q1(百萬)2020Q1(百萬)YoY(%)
105.063.066.666

EPS較上季

2021Q3(元)2021Q2(元)比率
2.310.543.2777

應收帳周轉率和存貨周轉率-近5年

20202019201820172016
應收帳款周轉率5.455.776.025.056.00
存貨周轉率2.432.341.991.902.72




應收帳周轉率和存貨周轉率-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
應收帳款周轉率1.671.271.601.551.721.001.001.34
存貨周轉率0.940.760.630.580.540.410.480.34




償債能力-近5年

20202019201820172016
負債比0.120.080.110.080.09
金融負債(百萬)00000
營業收入淨額(百萬)76510149639371151
利息保障倍數785.45222.990.000.000.00
長期銀行借款占稅後淨利比0.000.000.000.000.00




償債能力-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
負債比0.210.200.210.120.110.200.220.08
金融負債(百萬)00000000
營業收入淨額(百萬)331235238210231141183236
利息保障倍數649.78294.67492.562717.88353.6370.63231.35271.01
長期銀行借款占稅後淨利比0.000.000.000.000.000.000.000.00




成本指標-近5年

20202019201820172016
營業收入淨額(百萬)76510149639371151
推銷費用(百萬)205374442381336
管理費用(百萬)6274625664
研究發展費(百萬)111210913
推銷費用率(%)26.8036.8845.9040.6629.19
管理費用率(%)8.107.306.445.985.56
研究發展費用率(%)1.441.181.040.961.13




成本指標-近8季

2021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
營業收入淨額(百萬)331235238210231141183236
推銷費用(百萬)5947545852474879
管理費用(百萬)1815162413101418
研究發展費(百萬)22233334
推銷費用率(%)17.8220.0022.6927.6222.5133.3326.2333.47
管理費用率(%)5.446.386.7211.435.637.097.657.63
研究發展費用率(%)0.600.850.841.431.302.131.641.69




財務健檢燈號

上市滿三年資本額10億以上股本形成中現金增資比率低於50%負債比率低於50%董監持股設質低於10%現金(含約當現金)占股本超過50%過去4季累積正營運現金流量過去4季ROE超過25%過去6個月的營收維持正的年成長率過去4季的EPS年增率是正數
OXOOOOOXOO
6年4.50億35.1%20.95%0.0%185.78%208百萬24.24%

融資使用率

日期股價融資使用率
2022-01-2589.811.14%
2022-01-2492.111.32%
2022-01-2189.911.51%
2022-01-2091.511.70%
2022-01-1992.411.87%
2022-01-1895.912.40%
2022-01-1794.012.83%
2022-01-1498.013.58%
2022-01-13100.514.01%
2022-01-1299.714.09%
2022-01-1199.614.12%
2022-01-10103.514.08%
2022-01-07100.514.08%
2022-01-06102.014.12%
2022-01-05101.514.14%
2022-01-04101.514.23%
2022-01-03100.514.29%
2021-12-30100.514.64%
2021-12-29107.515.26%
2021-12-2899.714.24%
2021-12-2799.314.23%
2021-12-24100.514.17%
2021-12-23100.014.16%
2021-12-22100.013.95%
2021-12-2199.613.91%
2021-12-2099.713.85%
2021-12-1798.513.77%
2021-12-16102.014.23%
2021-12-15101.014.69%
2021-12-14103.513.60%
2021-12-13113.512.39%
2021-12-10119.511.81%
2021-12-09109.011.34%
2021-12-08121.011.60%
2021-12-07132.010.64%
2021-12-06146.59.87%
2021-12-03144.010.14%
2021-12-02144.010.16%
2021-12-01151.010.21%
2021-11-30147.010.59%
2021-11-29138.010.83%
2021-11-26140.511.29%
2021-11-25142.511.34%
2021-11-24148.511.29%
2021-11-23148.511.25%
2021-11-22136.011.31%
2021-11-19141.510.82%
2021-11-18131.59.89%
2021-11-17127.09.97%
2021-11-16122.58.41%
2021-11-15111.57.97%
2021-11-12101.56.92%
2021-11-1195.26.62%
2021-11-1094.46.07%
2021-11-0988.55.81%
2021-11-0885.55.89%
2021-11-0581.25.98%
2021-11-0483.96.11%
2021-11-0387.86.04%
2021-11-0285.76.24%
2021-11-0190.06.33%
2021-10-2994.06.68%
2021-10-2890.06.31%
2021-10-2788.56.26%
2021-10-2687.76.19%
2021-10-2587.36.46%
2021-10-2286.36.45%
2021-10-2186.06.32%
2021-10-2085.86.41%
2021-10-1987.36.49%
2021-10-1886.76.54%
2021-10-1585.56.54%
2021-10-1484.46.91%
2021-10-1385.46.98%
2021-10-1284.06.91%
2021-10-0883.06.58%
2021-10-0783.16.57%
2021-10-0682.76.50%
2021-10-0581.06.35%
2021-10-0477.36.17%
2021-10-0180.06.57%
2021-09-3084.26.66%
2021-09-2981.36.41%
2021-09-2880.16.38%
2021-09-2779.46.42%
2021-09-2479.36.20%
2021-09-2378.85.91%
2021-09-2277.16.05%
2021-09-1777.06.07%
2021-09-1677.16.07%



沒有留言:

張貼留言